Literature DB >> 22282214

[An indirect estimation of current and future inequalities in the frequency of end stage renal disease in Mexico].

Francisco Franco-Marina1, Laura Leticia Tirado-Gómez, Aída Venado Estrada, José Andrés Moreno-López, Reyna Lizette Pacheco-Domínguez, Luis Durán-Arenas, Malaquías López-Cervantes.   

Abstract

OBJECTIVE: To describe current and future health inequalities in End Stage Renal Disease in Mexico (ESRD) in Mexican states with varying degrees of marginality.
MATERIAL AND METHODS: Using results, obtained by us in 2009, of an indirect estimation of incidence, prevalence, and mortality rates, and of the average case duration, we grouped these data according to the social deprivation level of the Mexican states. We measured health inequalities using the Health Concentration Index.
RESULTS: We found rising inequalities, between 2005 and 2025, in ESRD incidence, prevalence and mortality rates, as well as in the average duration of cases.
CONCLUSION: We project an important increase in the prevalence of ESRD for 2025 which will be greater in the Mexican states with more marginality. This will increase health inequities already present and represent important challenges for health care financing, especially if no action is taken to control the causes and progression of ESRD.

Entities:  

Mesh:

Year:  2011        PMID: 22282214     DOI: 10.1590/s0036-36342011001000015

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  6 in total

Review 1.  Acute kidney injury in pregnancy and the role of underlying CKD: a point of view from México.

Authors:  Margarita Ibarra-Hernández; Oralia Alejandra Orozco-Guillén; María Luz de la Alcantar-Vallín; Ruben Garrido-Roldan; María Patricia Jiménez-Alvarado; Kenia Benitez Castro; Francisco Villa-Villagrana; Mario Borbolla; Juan Manuel Gallardo-Gaona; Guillermo García-García; Norberto Reyes-Paredes; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2017-10-11       Impact factor: 3.902

2.  Mortality in Patients With Chronic Renal Disease Without Health Insurance in Mexico: Opportunities for a National Renal Health Policy.

Authors:  Rafael Valdez-Ortiz; Francisco Navarro-Reynoso; Ma Guadalupe Olvera-Soto; Geovana Martin-Alemañy; Adrian Rodríguez-Matías; Clara Rocío Hernández-Arciniega; Mario Cortes-Pérez; Ernesto Chávez-López; Gloria García-Villalobos; Héctor Hinojosa-Heredia; Ana Yetzin Camacho-Aguirre; Ángel Valdez-Ortiz; Guillermo Cantú-Quintanilla; Irma Gómez-Guerrero; Arturo Reding; Monserrat Pérez-Navarro; Gregorio Obrador; Ricardo Correa-Rotter
Journal:  Kidney Int Rep       Date:  2018-06-20

3.  [Empowerment and social support for patients with chronic kidney disease: case study in Michoacán, MexicoEmpoderamento e apoio social de pacientes com nefropatia crônica: estudo de caso em Michoacán, México].

Authors:  María Fernanda Carrillo Vega; Blanca Estela Pelcastre Villafuerte; Guillermo Salinas Escudero; Luis Durán Arenas; Y Malaquías López Cervantes
Journal:  Rev Panam Salud Publica       Date:  2017-12-12

4.  Health Needs Assessment: Chronic Kidney Disease Secondary to Type 2 Diabetes Mellitus in a Population without Social Security, Mexico 2016-2032.

Authors:  Silvia Martínez-Valverde; Rodrigo Zepeda-Tello; Angélica Castro-Ríos; Filiberto Toledano-Toledano; Hortensia Reyes-Morales; Adrián Rodríguez-Matías; Juan Luis Gerardo Durán-Arenas
Journal:  Int J Environ Res Public Health       Date:  2022-07-25       Impact factor: 4.614

5.  Health care trajectories and barriers to treatment for patients with end-stage renal disease without health insurance in Mexico: a mixed methods approach.

Authors:  Marcela Agudelo-Botero; María Cecilia González-Robledo; Hortensia Reyes-Morales; Liliana Giraldo-Rodríguez; Mario Rojas-Russell; Dolores Mino-León; Dayan Irene Ocampo-Morales; Rafael Valdez-Ortiz
Journal:  Int J Equity Health       Date:  2020-06-08

6.  Overview of the burden of chronic kidney disease in Mexico: secondary data analysis based on the Global Burden of Disease Study 2017.

Authors:  Marcela Agudelo-Botero; Rafael Valdez-Ortiz; Liliana Giraldo-Rodríguez; María Cecilia González-Robledo; Dolores Mino-León; María Fernanda Rosales-Herrera; Lucero Cahuana-Hurtado; Mario Enrique Rojas-Russell; Claudio Alberto Dávila-Cervantes
Journal:  BMJ Open       Date:  2020-03-25       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.